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Research
Rheumatoid arthritis (RA) is a chronic auto­
immune disease with unknown etiology, 
although epidemiologic studies suggest genetic 
and environmental factors may play a role. 
Research on other chronic autoimmune dis­
eases including lupus erythematosus, dermato­
myositis, polymyositis, and vasculitis has 
shown geographic associations with higher lati­
tudes (Gatenby et al. 2009; Hengstman et al. 
2000; Somers et al. 2007; Walsh and Gilchrist 
2006). Geographic variation in incident RA 
has been observed at the regional level accord­
ing to state of residence (Costenbader et al. 
2008a). The findings suggested an increased 
risk of RA for women who lived in the mid­
western and eastern United States compared 
with the west, and the association was stronger 
with residency at ages 15 and 30 years than at 
baseline in 1976. In their review, Alamanos 
et al. (2006) also showed that RA varies geo­
graphically in areas of the world, with south­
ern European countries having lower median 
incidence rates than northern European coun­
tries and North America. Ramos­Remus et al. 
(2007) observed that the mean age of RA 
onset was much younger among Mexicans 
than among Canadians. In another study, 
Anaya et al. (2001) found that RA is rare in 
African populations.
To explore further the association between 
location and RA risk, we analyzed individual­ 
level residential data from U.S. women who 
participated in the Nurses’ Health Study 
(NHS). This prospective cohort study provides 
information on personal covariates and partici­
pant mobility prior to RA onset. Residential 
histories are particularly useful when exposures 
of interest are time dependent. We conducted 
spatial analyses that considered time measured 
by calendar year and by year of diagnosis for 
cases or censoring for controls. Generalized 
additive models (GAMs), a type of statistical 
model that combines smoothing with the abil­
ity to analyze binary outcome data and adjust 
for covariates, provide a useful framework for 
examining point data (Hastie and Tibshirani 
1990; Kelsall and Diggle 1998; Webster et al. 
2006). Using individual­level information and 
location in a GAM, we calculated the crude 
and adjusted odds ratios for incident RA in 
the United States. This method has the advan­
tage of controlling for spatial confounders and 
of allowing for hypothesis testing for the sig­
nificance of location in the disease maps. The 
objectives of the present analyses are to exam­
ine geographic variation at the individual level 
and to identify potential exposure hypotheses 
for further investigation.
Methods
Study population. We investigated the associa­
tion between residence and incident RA using 
data from the NHS, a long­term prospective 
cohort study of U.S. female nurses. In 1976, at 
the study’s inception, 121,700 nurses, 30–55 
years old, who lived in 11 states (California, 
Connecticut,  Florida,  Massachusetts, 
Maryland, Michigan, New Jersey, New York, 
Ohio, Pennsylvania, and Texas) and who were 
recruited through the state licensing boards, 
completed a mailed self­administered question­
naire and provided informed consent (Hart 
et al. 2009; Oh et al. 2005; Stampfer et al. 
2000). Every 2 years, participants are mailed 
follow­up questionnaires to update current resi­
dential addresses, health outcomes, and behav­
ioral risk factors. The addresses for 103,341 
nurses from the 1988–2002 questionnaire 
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Ba c k g r o u n d: The etiology of rheumatoid arthritis (RA) remains largely unknown, although epi­
demio  logic studies suggest genetic and environmental factors may play a role. Geographic variation 
in incident RA has been observed at the regional level.
oB j e c t i v e: Spatial analyses are a useful tool for confirming existing exposure hypotheses or generating 
new ones. To further explore the association between location and RA risk, we analyzed individual­
level data from U.S. women in the Nurses’ Health Study, a nationwide cohort study.
Me t h o d s : Participants included 461 incident RA cases and 9,220 controls with geocoded addresses; 
participants were followed from 1988 to 2002. We examined spatial variation using addresses at 
baseline in 1988 and at the time of case diagnosis or the censoring of controls. Generalized additive 
models (GAMs) were used to predict a continuous risk surface by smoothing on longitude and lati­
tude while adjusting for known risk factors. Permutation tests were conducted to evaluate the overall 
importance of location and to identify, within the entire study area, those locations of statistically 
significant risk.
re s u l t s: A statistically significant area of increased RA risk was identified in the northeast United 
States (p­value = 0.034). Risk was generally higher at northern latitudes, and it increased slightly 
when we used the nurses’ 1988 locations compared with those at the time of diagnosis or censoring. 
Crude and adjusted models produced similar results.
co n c l u s i o n s: Spatial analyses suggest women living in higher latitudes may be at greater risk for 
RA. Further, RA risk may be greater for locations that occur earlier in residential histories. These 
results illustrate the usefulness of GAM methods in generating hypotheses for future investigation 
and supporting existing hypotheses.
key w o r d s : disease mapping, generalized additive models, geographic information systems 
(GIS), prospective cohort study, rheumatoid arthritis. Environ Health Perspect 118:957–961 
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cycles were geocoded, which contributed 
173,624 addresses and 762,511 questionnaire 
records. Although nurses’ addresses were con­
centrated in the 11 original study states at 
baseline in 1976, by the follow­up period in 
2002, the women were located in all 50 states. 
The medical records of nurses were reviewed to 
identify those who self­reported a diagnosis of 
RA. In this study, we used the diagnostic crite­
ria of the American College of Rheumatology 
for RA (Karlson et al. 1995, 2004). For 1988 
through 2002, we identified a total of 461 
women with confirmed incident RA. When the 
participants reported having RA, their informa­
tion was censored, and their residential history 
was considered complete at that time. We used 
incidence density sampling to randomly select 
20 controls per case from among the noncases 
for a total of 9,220 controls (Richardson 2004). 
Selecting 20 controls per case allowed us to ana­
lyze the geographic distribution of the popu­
lation under study and to keep the numbers 
reasonable for computation. Women who were 
noncases with a geocoded address at the time 
a case was diagnosed were eligible to be a con­
trol. Once selected, information for controls 
was censored, and their residential history was 
considered complete at that time. Thus, the 
proportion of participants censored in each year 
was the same for cases and controls.
Spatial analysis. We estimated disease 
odds using GAMs, a form of nonparametric 
or semiparametric regression with the ability 
to analyze binary and continuous outcome 
data while adjusting for covariates (Hastie and 
Tibshirani 1990; Kelsall and Diggle 1998; 
Webster et al. 2006). We modeled location, 
a potential surrogate measure of exposure, 
using a bivariate smooth (S) of longitude and 
latitude (x1) and (x2)
  logit[p(x1,x2)] = S(x1,x2) + γ´z ,   [1]
where the left­hand side is the log of the 
disease odds at location (x1,x2), z is a vector of 
covariates, and γ is a vector of parameters. The 
model is semiparametric because it has the 
nonparametric smooth, but the covariates are 
modeled parametrically. Without the smooth 
function, S(x1,x2), the model becomes an 
ordinary logistic regression on the covariates. 
To examine if timing of residential location 
impacts RA risk, we conducted analyses using 
1988 addresses (the earliest available that were 
geocoded) and the addresses at time of diag­
nosis or censoring for all participants.
Spatial confounding occurs when risk fac­
tors for a disease are not evenly distributed. 
A group of core confounders, chosen a pri‑
ori based on the current scientific literature 
(Costenbader et al. 2006; Liao et al. 2009; 
Uhlig et al. 1999) or study design, was 
included in the analyses and modeled as shown 
in Table 1 unless otherwise noted: age, non­
Caucasian race, age at menarche, parity, total 
months of lactation, current menopausal 
status, menopausal hormone use, oral con­
traceptive use, physical activity, body mass 
index (BMI; modeled categorically), cigarette 
pack­years (calculated as the number of packs 
per day multiplied by the number of years of 
cigarette smoking), current smoking status, 
and socioeconomic status measured by nurses’ 
educational level, occupation of both parents, 
marital status, and husband’s education (if 
applicable). These variables were obtained from 
the questionnaire cycle that corresponded to 
the addresses used in the 1988 analysis (i.e., we 
used nurses’ BMI reported in the 1988 ques­
tionnaire for the analysis of 1988 addresses, 
and the BMI reported in the questionnaire at 
year of diagnosis or censoring for the analysis 
of addresses at time of diagnosis or censoring).
We used a loess smooth, which adapts to 
changes in population density (Hastie and 
Tibshirani 1990) and determined the opti­
mal amount of data for the smooth, or span 
size, for each map by minimizing the Akaike’s 
Information Criterion (AIC). A rectangular 
grid covering the continental United States was 
created using the minimum and maximum 
longitude and latitude from the study subjects. 
Because GAMs may exhibit biased behavior at 
the edges of the data, the study area for spatial 
Table 1. Selected characteristics of cases and controls in 1988 and at the time of diagnosis or censoring.
Cases (n = 461) Controls (n = 9,220)
Characteristics 1988 Dx 1988 Dx
Mean age (years)a 54.8 61.4 54.4 61.0
BMI (kg/m2) 23.5 26.0 22.5 24.5
Mean age at menarche (years)  12.4 12.4 12.4 12.4
Pack-years of smoking (mean)b  26.3 27.8 23.0 24.6
Caucasian race (%) 94.1 94.1 93.8 93.8
Smoking status (%)
Current  18.4 13.2 19.1 13.8
Former  40.8 48.6 34.2 40.0
Never  37.7 37.7 43.8 43.6
Parity/lactation (%)
Nulliparous  6.7 6.7 7.0 7.0
Parous, never breast-fed  34.1 34.1 29.5 29.5
Parous, breast-fed 1–11 months  36.9 36.9 35.0 35.0
Parous, breast-fed ≥ 12 months  12.8 12.8 15.8 15.8
Menopausal status (%)
Premenopausal  20.8 6.3 25.8 10.7
Postmenopausal  75.3 93.1 68.7 85.9
Unknown status  3.9 0.6 5.5 3.4
Postmenopausal hormone use (%)c
Never used  50.7 33.0 52.4 33.7
Past use  13.4 19.7 11.7 17.9
Current use  26.2 40.6 19.3 31.8
Oral contraceptive use (%)
Never used  48.6 48.6 50.2 50.2
Ever used  48.6 48.6 45.0 45.0
Physical activity (metabolic equivalent hours/week, %)
< 3  17.6 20.8 17.0 17.2
3 to < 9  23.6 20.0 19.7 18.1
9 to < 18  16.9 20.2 15.6 16.0
18 to < 27  10.2  10.8 8.7 9.9
≥ 27  15.2 19.3 12.9 15.9
Father’s occupation (%)
Professional/manager  23.6 23.6 25.4 25.4
Other job  76.4 76.4 74.6 74.6
Mother’s occupation (%)
Housewife  67.5 67.5 64.2 64.2
Other job  32.5 32.5 35.8 35.8
Education (%)
Nurse  84.2 84.2 72.4 72.4
Other  15.8 15.8 27.6 27.6
Marital status (%)
Married  71.6 71.6 63.2 63.2
Other  28.4 28.4 36.8 36.8
Husband’s education (%)
Missing or not applicable  22.8 22.8 34.6 34.6
< High school  6.1 6.1 3.9 3.9
High school  31.7 31.7 25.7 25.7
> High school  39.5 39.5 35.7 35.7
Dx, diagnosis or censoring. 
aAge was originally modeled in months but converted to years for this paper. bAmong ever-smokers. cAmong post-
menopausal women.Spatial analysis of RA
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model predictions is the continental United 
States, excluding regions of low population 
density along the geographic edges of our study 
population. Using sensitivity analyses to deter­
mine the impact of sparse data areas on the 
predicted results, we identified the midwest 
(Great Plains), northern Maine, and south­
west Texas as low population density regions. 
In these regions, a participant’s nearest neigh­
bor was > 200 km away along the geographic 
edges of the study population. We converted 
log odds to odds ratios (ORs) using the odds of 
disease in the whole study area as the reference.
GAMs also provide a framework for 
hypothesis testing. We first tested the null 
hypothesis that case status does not depend 
on the smooth term, using a permutation 
test based on the difference of the deviances 
of equation 1with and without the smooth 
term (Webster et al. 2006). We discuss results 
as significant if the associated p­values are 
< 0.05, but acknowledge that some results 
may be due to chance. If the global deviance 
test indicated that geographic location is 
important, we examined pointwise departures 
from the null hypothesis using permutation 
tests to identify areas of the map that exhibit 
unusually high or low disease odds. We used 
contour lines to denote areas of significant 
decreased RA risk (points that ranked in the 
lower 2.5% of the pointwise permutation dis­
tributions, indicating low disease odds) or 
increased RA risk (upper 2.5% of the point­
wise permutation distributions, indicating 
high disease odds). We used S­Plus (version 
8.0; Insightful Corp., Somerville, MA) to per­
form the generalized additive modeling and 
a geographic information system (ArcGIS, 
version 9.3; ESRI, Redlands, CA) to map 
the results of our analyses. The institutional 
review boards of Boston University Medical 
Center and Brigham and Women’s Hospital 
approved the research.
Results
Participants were predominantly white and 
> 50 years old (Table 1). Cases were more likely 
to be former smokers and current users of post­
menopausal hormones. Higher proportions of 
controls were never­smokers and breast fed for 
at least 1 year. As expected, more women were 
postmenopausal at time of diagnosis (for cases) 
or censoring (for controls) than in 1988. There 
were also more physically active women and 
fewer current smokers at the time of diagnosis 
or censoring. Cases were more likely to have 
moved than were controls; 31.4% (145/461) 
of cases moved between 1988 and year of diag­
nosis, whereas 26.6% (2,455/9,220) of controls 
moved between 1988 and year of censoring. 
Covariate data were missing for < 10% of par­
ticipants with the exception of information 
on postmenopausal hormone use (17%) and 
physical activity (23%).
Figure 1 shows the distribution of RA 
cases and controls in the United States using 
address at diagnosis or censoring. To preserve 
confidentiality, the figure was created by ran­
domly placing residences within a small grid 
that included the actual location. Actual loca­
tions were used in the analysis.
When geographic variation in RA risk was 
examined using addresses at diagnosis or censor­
ing, the crude and adjusted analyses (Figure 2A 
and 2B, respectively) predicted similar results. 
Because of low data density and thus unreliable 
estimates, we did not predict odds of RA for 
regions shown in white. The association between 
location and RA was statistically significant for 
both analyses (crude, global p­values = 0.02; 
adjusted, global p­value = 0.034), indicating 
that ORs of RA varied with geographic loca­
tion. Contour lines denote areas where RA 
risk relative to the whole study area was signifi­
cantly increased (red) and decreased (blue) at 
the 0.05 level. A statistically significant area of 
increased risk was identified in the upper north­
east including Vermont, New Hampshire, and 
southern Maine. A significant area of decreased 
risk was located in Pennsylvania. The optimal 
spans for the crude and adjusted analyses were 
0.55 and 0.5, respectively. Crude ORs (CORs) 
ranged from 0.76 to 2.26, only slightly larger 
than adjusted ORs (AORs), which ranged from 
0.68 to 2.17.
Figure 3A shows the results of the adjusted 
analysis using 1988 residences with the opti­
mal span of 0.55. Again, similar spatial pat­
terns of predicted risk were found between 
the adjusted and crude analysis (not shown). 
Crude and adjusted maps predicted compa­
rable ranges in ORs relative to the whole study 
area (COR = 0.61–2.39; AOR = 0.63–2.37), 
and both were statistically significant (global 
p­values of 0.029 and 0.034, respectively). We 
performed pointwise tests of significance and 
identified areas of higher risk in the northern 
areas in the midwest and northeast denoted 
by red contour lines. The AIC curve for the 
adjusted RA model indicated a local minima 
at span sizes of 0.20 before reaching the global 
minimum (and optimal span) of 0.55. We 
repeated the adjusted analysis using a span 
of 0.20 (Figure 3B). The small span of 0.20 
produced a surface with more spatial variation 
in risk, including an area of high ORs along 
the Ohio River near West Virginia and north­
ern Kentucky. The model also predicted even 
higher ORs in the northern latitudes, the west, 
the midwest (Great Plains), and the northeast. 
We did not test for statistical significance of 
location in this model because the optimal 
span size was not used.
Discussion
Results of the spatial analysis are consistent 
with an earlier regional study conducted by 
Costenbader et al. (2008a) that found increased 
risk of RA for those women who lived in the 
midwest and northeast United States, com­
pared with west of the Rocky Mountain range, 
and the association was stronger with residency 
at age 15 and 30 years than at baseline in 1976. 
They also observed elevated risk in the mid­
Atlantic region compared with the area west 
of the Rocky Mountain range, which the cur­
rent spatial analysis did not observe. Although 
both studies used the NHS data set, possible 
reasons for the difference in results include 
study population (the earlier study included 
women diagnosed with RA beginning in 1976 
compared with 1988 in the current study), 
reference group (west of the Rocky Mountain 
range compared with the entire study area), 
Figure 1. Distribution of cases and controls for RA. Each point represents the residences for cases (red) at 
diagnosis and controls (blue) at time of censoring. Locations have been geographically altered to preserve 
confidentiality.
0 250 500 1,000 kmVieira et al.
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and geographic scale (regional versus individ­
ual­level analyses). The time periods of the 
addresses were different as well. We examined 
risk of RA using addresses from 1988 (when 
the mean age for the current study popula­
tion was 54 years old) and those at diagno­
sis or censoring. These two time points were 
not considered in the earlier regional study 
(Costenbader et al. 2008a). Although the NHS 
began in 1976, addresses were only geocoded 
beginning in 1988, which limited our ability to 
perform extensive space–time analyses (Vieira 
et al. 2008).
Spatial patterns were similar for addresses 
in 1988 and at the time of diagnosis or cen­
soring (Figures 2B and 3A), although slightly 
higher ORs were observed for the 1988 
analysis. This finding suggests that long­term 
exposure may be more important than recent 
exposure. We observed even higher ORs when 
we restricted the 1988 analysis to women who 
were diagnosed or censored at least 8 years later 
(1996 or later; data not shown). Although this 
restricted analysis was limited by small case 
numbers (n = 227), it supports our hypothesis 
that earlier rather than recent exposure may 
be more important. Regardless of timing, a 
statistically significant area in the upper north­
east that included Vermont, New Hampshire, 
and southern Maine was identified as having 
consistently elevated RA risk relative to the 
whole study area, and an additional analysis 
(Figure 3B) predicted increased ORs for the 
more northern latitudes of the United States. 
A geographic association with northern lati­
tudes has also been observed for multiple scle­
rosis and Crohn’s disease. These autoimmune 
diseases may be mediated by a reduction in 
vitamin D through decreased solar exposure 
and the immune effects of vitamin D defi­
ciency (Armitage et al. 2004; Arnson et al. 
2007; Hernán et al. 1999; Kamen et al. 2006; 
McLeod et al. 1994; Munger et al. 2006; Patel 
et al. 2007; Ponsonby et al. 2005; Sioka et al. 
2009). The studies of dietary intake of vitamin 
D and incident RA have come to contradictory 
conclusions. Merlino et al. (2004) found 
a strong protective effect of high vitamin D 
intake in diminishing incident RA, whereas a 
study by Costenbader et al. (2008b) revealed 
no association between intake and incident 
RA. However neither study assessed vitamin D 
from solar exposure.
Geographic variation may also be due to 
other environmental exposures or residual 
spatial confounding. Spatial confounding 
occurs when risk factors for a disease are not 
evenly distributed. For example, a cluster of 
lung cancer may be due to an increased den­
sity of smokers. Crude and adjusted analyses 
produced similar geographic patterns of RA 
risk, and missing covariate data were not a con­
cern in our analyses. Although we adjusted for 
individual­level socioeconomic status, some 
authors argue for the inclusion of group­level 
contextual variables (e.g., Krieger et al. 2002). 
By linking residential location to census data, 
one could test the importance of these variables 
relative to individual­level covariates. We are 
Figure 2. Results for addresses at time of diagnosis or censoring. ORs are relative to the whole study area. (A) Crude, optimal span of 0.55 (global p = 0.02). 
(B) Adjusted, optimal span of 0.50 (global p = 0.034). Contour lines denote areas of significantly increased (red) and decreased (blue) risk at the 0.05 level. 
Geographic patterns are similar for crude and adjusted analyses.
ORs
0.25 2.25 1.00
Figure 3. Results for addresses in 1988. ORs are relative to the whole study area. (A) Adjusted, optimal span of 0.55 (global p = 0.034); contour lines denote areas of 
significantly increased (red) and decreased (blue) risk at the 0.05 level. (B) Adjusted, span of 0.20. Small span size results in more spatial variation in risk.
ORs
0.25 2.25 1.00Spatial analysis of RA
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currently working on methods involving gen­
eralized additive mixed models to incorporate 
a smooth of location into a multilevel model 
adjusted for individual­ and community­level 
risk factors. Our findings also may be due to 
geographic differences in the location of rheu­
matology specialists or in diagnosing practices.
These spatial analyses have some potential 
limitations. GAMs may exhibit biased behav­
ior at the edges of the data, although our work 
with synthetic data suggested little to no bias 
when a loess smooth is used (Webster et al. 
2006). To reduce the likelihood of bias from 
edge effects, we did not predict ORs in regions 
of low data density, which restricted the extent 
of northern latitudes available for our analysis. 
We used the AIC to choose an optimal span, 
but when we used a smaller span of 0.20 in 
our analyses, we were able to discern greater 
spatial variation that may be of importance. 
Although there is some benefit to having a 
non–ad hoc method for span selection, analy­
ses should not be limited to just one span. In 
the current analyses, we identified areas with 
significantly increased or decreased risk using 
pointwise hypothesis tests only if global tests 
were statistically significant, but performing 
multiple testing at each location may result in 
an increase in the type I error rate. In addition, 
many epidemiologists prefer confidence inter­
vals when evaluating the precision of point 
estimates in addition to p­values (Rothman 
and Greenland 1998). It should be possible 
to compute variance bands (also known as 
confidence bands) for our maps, but display­
ing three surfaces of ORs makes it difficult to 
visually interpret points where the bands do 
not include one (Hastie and Tibshirani 1990).
Prospective cohort studies are one of the 
standard epidemiologic tools for investigating 
associations between disease and exposure. By 
combining such data with advanced statisti­
cal techniques, we were able to address many 
criticisms of spatial studies. Self­reported cases 
were confirmed by examining medical records, 
and controls selected from among the non­
cases provided an estimate of the underlying, 
nonuniform population from which the cases 
arose. Because the data are from a prospec­
tive cohort, selection bias is not a concern in 
this study. However, results for this spatial 
analysis of a female nurse cohort may not be 
generalizable to other populations. Point­
based data were used, avoiding aggregation 
within administrative boundaries. We were 
able to control for a large number of cova­
riates, which can be done only to a limited 
degree using other cluster analysis tools like 
the scan statistic (Kulldorff 1997). Residential 
history information allowed us to take cal­
endar year into account, potentially quite 
important for diseases with environmental risk 
factors. Although spatial analyses are useful 
for generating new hypotheses or supporting 
existing hypotheses, areas of increased and 
decreased ORs should be considered explor­
atory. Further analysis that examines the rela­
tionship between vitamin D exposure and RA 
is warranted to explore these results.
Conclusions
Using GAMs and GIS, we generated maps 
of RA risk relative to the whole study area. 
When available, prospective cohort studies 
provide extensive data on potential risk factors 
and residential histories that address many 
methodological criticisms of cluster studies. 
We identified a significant area of increased 
ORs in the northeast, and additional analyses 
suggest that women living in more northern 
latitudes may be at greater risk for RA relative 
to the whole study area. Similar geographic 
associations have been observed with other 
chronic autoimmune diseases including mul­
tiple sclerosis. The results of the current analy­
sis illustrate the application of GAMs and GIS 
to visualize geographic variation in RA risk, 
adjust for known confounders, and test for the 
statistical significance of location. Our method 
is particularly useful in generating hypotheses 
for further investigation and supporting exist­
ing hypotheses, especially when residential 
histories are available.
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